Skip to main content
CriticalFDAfda-F-0320-2024UNDECLARED ALLERGEN

Kula Can Pin¿a Colada + KRATOM SELTZER, 12 oz (355ML) DIETARY SUPPLEMENT

⚠ Critical Alert — Stop Using Immediately

This product has been flagged with severe risks (undeclared allergen). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.

Category
Units Affected
7,062
Recall Date
September 21, 2023
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0320-2024.

Undeclared Allergens: Milk and Tree Nut (Coconut) and Unapproved Food Additive: Kratom

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0320-2024.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Kula Brands Llc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0320-2024.

Kula Brands LLC

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Kula Brands Llc Recall FAQ

Kula Brands Llc is the subject of a supplements safety report: Kula Can Pin¿a Colada + KRATOM SELTZER, 12 oz (355ML) DIETARY SUPPLEMENT. The notice was published on September 21, 2023 by the U.S. Food and Drug Administration (FDA). Approximately 7,062 units are potentially affected.